313 related articles for article (PubMed ID: 38265598)
1. When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development.
Chen B; Zeng G; Sun L; Jiang C
Sci China Life Sci; 2024 May; 67(5):854-864. PubMed ID: 38265598
[TBL] [Abstract][Full Text] [Related]
2. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
Li N; Dai Z; Wang Z; Deng Z; Zhang J; Pu J; Cao W; Pan T; Zhou Y; Yang Z; Li J; Li B; Ran P
Respir Res; 2021 Oct; 22(1):274. PubMed ID: 34696775
[TBL] [Abstract][Full Text] [Related]
4. Smoking-induced microbial dysbiosis in health and disease.
Shapiro H; Goldenberg K; Ratiner K; Elinav E
Clin Sci (Lond); 2022 Sep; 136(18):1371-1387. PubMed ID: 36156126
[TBL] [Abstract][Full Text] [Related]
5. Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice.
Hilty M; Wüthrich TM; Godel A; Adelfio R; Aebi S; Burgener SS; Illgen-Wilcke B; Benarafa C
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33295863
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Impact of Tobacco Usage on Microbiome Dysbiosis and Associated Health Risks: A Comprehensive Review of Recent Advancements and Future Directions.
Donato K; Donato K; Bonetti G; Cristoni S; Connelly ST; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):119-125. PubMed ID: 37994755
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
8. The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease.
Wang L; Cai Y; Garssen J; Henricks PAJ; Folkerts G; Braber S
Am J Respir Crit Care Med; 2023 May; 207(9):1145-1160. PubMed ID: 36883945
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
Lim EY; Song EJ; Shin HS
J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota dysbiosis contributes to the development of hypertension.
Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
[TBL] [Abstract][Full Text] [Related]
13. Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome.
Martinez JE; Kahana DD; Ghuman S; Wilson HP; Wilson J; Kim SCJ; Lagishetty V; Jacobs JP; Sinha-Hikim AP; Friedman TC
Front Endocrinol (Lausanne); 2021; 12():667066. PubMed ID: 34168615
[TBL] [Abstract][Full Text] [Related]
14. Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms.
Chi L; Tu P; Ru H; Lu K
Gut Microbes; 2021; 13(1):1921912. PubMed ID: 34313531
[TBL] [Abstract][Full Text] [Related]
15. Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome.
Chae YR; Lee YR; Kim YS; Park HY
J Microbiol Biotechnol; 2024 Apr; 34(4):747-756. PubMed ID: 38321650
[TBL] [Abstract][Full Text] [Related]
16. Emerging pathogenic links between microbiota and the gut-lung axis.
Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
Kang Y; Cai Y
J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
[TBL] [Abstract][Full Text] [Related]
18. Eubiosis and dysbiosis: the two sides of the microbiota.
Iebba V; Totino V; Gagliardi A; Santangelo F; Cacciotti F; Trancassini M; Mancini C; Cicerone C; Corazziari E; Pantanella F; Schippa S
New Microbiol; 2016 Jan; 39(1):1-12. PubMed ID: 26922981
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and the development of pediatric diseases.
Lu CY; Ni YH
J Gastroenterol; 2015 Jul; 50(7):720-6. PubMed ID: 25917564
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review.
Song W; Yue Y; Zhang Q
Biomed Pharmacother; 2023 Sep; 165():115150. PubMed ID: 37429232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
